Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Tuberculosis

  Free Subscription


12.04.2021

1 Am J Respir Crit Care Med
1 Antimicrob Agents Chemother
1 Clin Infect Dis
1 Eur J Clin Microbiol Infect Dis
3 Eur Respir J
6 Int J Tuberc Lung Dis
1 J Clin Microbiol
6 PLoS One
1 Trop Med Int Health


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. HUDDART S, Savic RM, Cattamanchi A
    Is Glycemic Control the Secret to Tuberculosis Control?
    Am J Respir Crit Care Med. 2021 Apr 7. doi: 10.1164/rccm.202103-0703.
    PubMed        


    Antimicrob Agents Chemother

  2. HAYASHI M, Nishiyama A, Kitamoto R, Tateishi Y, et al
    Adduct Formation of Delamanid with NAD in Mycobacteria.
    Antimicrob Agents Chemother. 2020;64.
    PubMed         Abstract available


    Clin Infect Dis

  3. HWANG H, Kang H, Kwon YS, Jeon D, et al
    Outcomes of multidrug-resistant tuberculosis treated with bedaquiline or delamanid.
    Clin Infect Dis. 2021 Apr 10. pii: 6219782. doi: 10.1093.
    PubMed         Abstract available


    Eur J Clin Microbiol Infect Dis

  4. NKWAGATSE T, Sturm AW
    Affinity of Mycobacterium tuberculosis strains for M059K microglial cells after migration through A549 alveolar epithelium.
    Eur J Clin Microbiol Infect Dis. 2021 Apr 9. pii: 10.1007/s10096-021-04226.
    PubMed         Abstract available


    Eur Respir J

  5. MAITRE T, Guglielmetti L, Veziris N
    Defining optimal fluoroquinolone exposure against Mycobacterium tuberculosis: contribution of murine studies.
    Eur Respir J. 2021;57.
    PubMed        

  6. SRIVASTAVA S, Gumbo T
    Therapeutic drug monitoring and fluoroquinolones for multidrug-resistant tuberculosis.
    Eur Respir J. 2021;57.
    PubMed        

  7. VINEY K, Linh NN, Gegia M, Zignol M, et al
    New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization.
    Eur Respir J. 2021;57.
    PubMed        


    Int J Tuberc Lung Dis

  8. AKKERMAN OW, Tiberi S
    The importance of knowing why TB patients stop anti-TB treatment.
    Int J Tuberc Lung Dis. 2020;24:989-990.
    PubMed        

  9. HELDAL E, Dlodlo RA
    Estimating subnational TB burden-why not strengthen and use routine recording and reporting?
    Int J Tuberc Lung Dis. 2020;24:1125-1127.
    PubMed        

  10. CHIANG CY, Bam TS
    The impact of smoking on TB treatment outcomes includes recurrent TB.
    Int J Tuberc Lung Dis. 2020;24:1224-1225.
    PubMed        

  11. DHAMGAYE TM
    In reply: Latent TB treatment in pregnant women: a patient perspective.
    Int J Tuberc Lung Dis. 2020;24:1226-1227.
    PubMed        

  12. WANG EY, Ahluwalia IB, Mase SR
    Response to Correspondence: The impact of smoking on TB treatment outcomes includes recurrent TB.
    Int J Tuberc Lung Dis. 2020;24:1225a-1225.
    PubMed        

  13. HAAS MK, Ignatius EH, Stout JE, Dooley KE, et al
    Finding the right balance between efficacy and tolerability for TB treatment.
    Int J Tuberc Lung Dis. 2020;24:1225b-1226.
    PubMed        


    J Clin Microbiol

  14. XIAO G, He X, Zhang S, Liu Y, et al
    Cas12a/Guide RNA-Based Platform for Rapid and Accurate Identification of Major Mycobacterium Species.
    J Clin Microbiol. 2020;58.
    PubMed         Abstract available


    PLoS One

  15. GWITIRA I, Karumazondo N, Shekede MD, Sandy C, et al
    Spatial patterns of pulmonary tuberculosis (TB) cases in Zimbabwe from 2015 to 2018.
    PLoS One. 2021;16:e0249523.
    PubMed         Abstract available

  16. MEKKAOUI L, Hallin M, Mouchet F, Payen MC, et al
    Performance of Xpert MTB/RIF Ultra for diagnosis of pulmonary and extra-pulmonary tuberculosis, one year of use in a multi-centric hospital laboratory in Brussels, Belgium.
    PLoS One. 2021;16:e0249734.
    PubMed         Abstract available

  17. HEWAGE S, Somasundaram N, Ratnasamy V, Ranathunga I, et al
    Active screening of patients with diabetes mellitus for pulmonary tuberculosis in a tertiary care hospital in Sri Lanka.
    PLoS One. 2021;16:e0249787.
    PubMed         Abstract available

  18. SANTOS FLD, Souza LLL, Bruce ATI, Crispim JA, et al
    Patients' perceptions regarding multidrug-resistant tuberculosis and barriers to seeking care in a priority city in Brazil during COVID-19 pandemic: A qualitative study.
    PLoS One. 2021;16:e0249822.
    PubMed         Abstract available

  19. THIEL BA, Worodria W, Nalukwago S, Nsereko M, et al
    Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0249477.
    PubMed         Abstract available

  20. JAKHAR S, Sakamuri R, Vu D, Dighe P, et al
    Interaction of amphiphilic lipoarabinomannan with host carrier lipoproteins in tuberculosis patients: Implications for blood-based diagnostics.
    PLoS One. 2021;16:e0243337.
    PubMed         Abstract available


    Trop Med Int Health

  21. CHANDRAN S, Rahman A, Norris JM, Tiberi S, et al
    Diagnostic Pitfalls of Urogenital Tuberculosis.
    Trop Med Int Health. 2021 Apr 4. doi: 10.1111/tmi.13583.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: